Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated June 26, 2026, except for the effects of the reverse stock split discussed in Note 13, as to which the date is October 5, 2026, with respect to the financial statements of TRex Bio, Inc., incorporated herein by reference.
/s/ KPMG LLP
San Francisco, California
October 9, 2026
